How does 197A's PE Ratio compare to its peers?

197A is good value based on its Price-To-Earnings Ratio (10.8x) compared to the peer average (27x).

How does 197A's PE Ratio compare vs other companies in the JP Medical Equipment Industry?

197A is good value based on its Price-To-Earnings Ratio (10.8x) compared to the JP Medical Equipment industry average (16.5x).

What is 197A's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

197A is good value based on its Price-To-Earnings Ratio (10.8x) compared to the estimated Fair Price-To-Earnings Ratio (15.7x).

What is the Fair Price of 197A when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

197A (¥618) is trading below our estimate of [[fair value]] (¥936.41)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Target price is less than 20% higher than the current share price.

197A Stock Overview

Engages in the development, manufacture, export/import, and sale of in vitro diagnostics and research reagents, and its intermediates in Japan and internationally. More details

197A fundamental analysis
Snowflake Score
Valuation	5/6
Future Growth	3/6
Past Performance	4/6
Financial Health	5/6
Dividends	4/6

Rewards

Trading at 34% below our estimate of its fair value

Earnings are forecast to grow 5.13% per year

Earnings grew by 90.3% over the past year

Trading at good value compared to peers and industry

Risk Analysis

Less than 3 years of financial data is available

Volatile share price over the past 3 months compared to the JP market

My Notes

Capture your thoughts, links and company narrative

TAUNS Laboratories,Inc. Competitors

Nagaileben

TSE:7447

JP¥65.1b

Eiken Chemical

TSE:4549

JP¥73.5b

Shofu

TSE:7979

JP¥75.9b

Hogy MedicalLtd

TSE:3593

JP¥104.7b

Price History & Performance

Summary of share price highs, lows and changes for TAUNS LaboratoriesInc
Historical stock prices
Current Share Price	JP¥618.00
52 Week High	JP¥733.00
52 Week Low	JP¥401.00
Beta	0
1 Month Change	-0.48%
3 Month Change	14.66%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	47.49%

Recent updates

Shareholder Returns

	197A	JP Medical Equipment	JP Market
7D	0.7%	0.3%	1.2%
1Y	n/a	11.0%	8.4%

Return vs Industry: Insufficient data to determine how 197A performed against the JP Medical Equipment industry.

Return vs Market: Insufficient data to determine how 197A performed against the JP Market.

Price Volatility

Is 197A's price volatile compared to industry and market?
197A volatility
197A Average Weekly Movement	7.0%
Medical Equipment Industry Average Movement	3.3%
Market Average Movement	3.5%
10% most volatile stocks in JP Market	7.3%
10% least volatile stocks in JP Market	1.9%

Stable Share Price: 197A's share price has been volatile over the past 3 months compared to the JP market.

Volatility Over Time: 197A's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of JP stocks.

About the Company

Founded	Employees	CEO	Website
1987	n/a	Masaki Nonaka	www.tauns.co.jp

TAUNS Laboratories,Inc. engages in the development, manufacture, export/import, and sale of in vitro diagnostics and research reagents, and its intermediates in Japan and internationally. It also offers medical physicochemical measuring equipment, industrial measuring equipment, and medical devices; and contract research services.

TAUNS Laboratories,Inc. Fundamentals Summary

How do TAUNS LaboratoriesInc's earnings and revenue compare to its market cap?
197A fundamental statistics
Market cap	JP¥62.34b
Earnings (TTM)	JP¥5.77b
Revenue (TTM)	JP¥18.43b

10.8x

P/E Ratio

3.4x

P/S Ratio

Is 197A overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
197A income statement (TTM)
Revenue	JP¥18.43b
Cost of Revenue	JP¥5.94b
Gross Profit	JP¥12.50b
Other Expenses	JP¥6.72b
Earnings	JP¥5.77b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Feb 13, 2025

Earnings per share (EPS)	57.24
Gross Margin	67.80%
Net Profit Margin	31.32%
Debt/Equity Ratio	69.8%

How did 197A perform over the long term?

See historical performance and comparison

Dividends

4.5%

Current Dividend Yield

18%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/31 20:22
End of Day Share Price	2025/01/31 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

TAUNS Laboratories,Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Yuki Yamazaki	Daiwa Securities Co. Ltd.
Tsuyoshi Ohno	Marusan Securities Co. Ltd.
Ryotaro Hayashi	Morgan Stanley